BURLINGAME, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Fast Melt Tablets Market is estimated to be valued at US$ 6.20 Bn in 2025 and is expected to reach US$ 11.41 Bn ...

Rising post-operative procedures and growing preference for injectable and oral pain management solutions are reshaping ketorolac market dynamics globally. This analysis integrates the most recent ...

The first Allergan lawsuit regarding textured breast implants and BIA-ALCL was filed in 2018. In 2019, all open cases were consolidated into a multidistrict litigation (MDL) in New Jersey.

4. Ethinyl estradiol, and norethindrone acetate and ferrous fumarate tablets from Allergan Sales are discontinued. 5. Metronidazole injections are discontinued from Pfizer Pharmaceuticals and ...

Both practices fall outside the riluzole label indication, and since there is no evidence on the efficacy and safety of crushed tablets, it may have an impact on absorption characteristics, cause ...

SUMMARY: The Food and Drug Administration (FDA) is withdrawing the approval of the new drug application (NDA) for ASACOL (mesalamine) delayed-release tablets, 400 milligrams (mg), held by Allergan ...

Ubrelvy, which comes in tablet form, can be effective in treating migraines with aura, a visual disturbance often associated with severe headaches, according to an agency statement. “Migraine is ...

AbbVie has its own problems. It’s buying Allergan because investors are worried about the expiration of its patents protecting Humira, the top-selling drug in the world, in 2023.

Abbvie spun off from Abbott Laboratories in 2013. Allergan had been expected to consider a potential split amid looming competition for wrinkle treatment Botox, according to Mizuho Securities ...

Allergan was testing the NMDA receptor modulator as an adjunct therapy in patients with major depressive disorder (MDD). In all, the three phase 3 studies enrolled 1,510 patients with MDD who had ...